MétaCan
Menu
Back to cohort
Record W4324117130 · doi:10.1016/j.gimo.2023.100445

P409: Clinical utility of genomic sequencing for hereditary cancer syndromes: An observational chart review

2023· article· en· W4324117130 on OpenAlexaff
Salma Shickh, Chloe Mighton, Marc Clausen, Rita Kodida, Jordan Sam, Daena Hirjikaka, Emma Reble, Tracy Graham, Seema Panchal, Andrea Eisen, Christine Elser, Kasmintan A. Schrader, Nancy N. Baxter, Andreas Laupacis, Jordan Lerner‐Ellis, Raymond H. Kim, Yvonne Bombard

Bibliographic record

VenueGenetics in Medicine Open · 2023
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicGenomics and Rare Diseases
Canadian institutionsCentre for Global Health ResearchSinai Health SystemUniversity Health NetworkHealth Sciences CentreSunnybrook Health Science Centre
Fundersnot available
KeywordsObservational studyGenomic sequencingComputational biologyCancerMedicineBiologyGeneticsBioinformaticsInternal medicineGenomeGene

Abstract

fetched live from OpenAlex

management approaches for hundreds of additional genetic disorders are available.Efforts such as the NIH-funded BabySeq Project explore the implications of genomic sequencing in healthy infants with the aim of designing strategies for implementation.Methods: We designed an online survey for rare disease experts (n = 389), investigating which additional treatable genetic conditions (currently not included on the RUSP) they recommend for screening in newborns using genomic sequencing.A list of 649 genes associated with treatable genetic conditions in 13 clinical areas was designed.Participants were invited to assess all proposed genes or to select the clinical area with which they were most familiar.We analyzed concordance among experts regarding screening specific genes in newborns.We also assessed responses to a series of descriptive questions about participant attitudes regarding universal genomic sequencing to screen newborns for treatable genetic disorders as well as the inclusion of disorders that are untreatable, lack confirmatory orthogonal tests, are of low penetrance, or are adult-onset.Results: A total of 238 (61.2%) experts, including directors of genetics and genomics programs accredited by the Accreditation Council for Graduate Medical Education (n = 64), physicians specializing in the care of rare disease patients (n = 165), and senior scientists within pharmaceutical companies specializing in rare disease therapeutics (n = 9) participated.Experts agreed with ≥85% concordance that 25 genes associated with disorders not currently included in universal NBS programs should be evaluated in presymptomatic infants (OTC, G6PC, SLC37A4, CYP11B1, ARSB, F8, F9, SLC2A1, CYP17A1, RB1, IDS, GUSB, DMD, GLUD1, CYP11A1, GALNS, CPS1, PLPBP, ALDH7A1, SLC26A3, SLC25A15, SMPD1, GATM, SLC7A7, NAGS).Orthogonal tests are available for confirmation of genetic disorders caused by 24 out of these 25 genes (96%).Clinical areas of interest included Metabolism, Neurology, Endocrinology and Hemato-Oncology.A total of 42 genes had ≥80% concordance and 432 genes had ≥50% concordance.Overall, 161 of 183 (87.9%) experts agreed or somewhat agreed that genomic sequencing should be used to expand the number of conditions included in NBS.Conclusion: While several of these genes are associated with clinical domains that are currently included in NBS, there are multiple candidates that represent new frontiers for NBS, such as hereditary cancer predisposition syndromes.This study highlights that experts endorse the expansion of NBS programs to include additional treatable monogenic disorders, including 25 high-priority conditions which could be efficiently screened using genomic sequencing.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.009
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.017
Threshold uncertainty score0.033

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.009
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0020.002
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.357
GPT teacher head0.488
Teacher spread0.131 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueGenetics in Medicine OpenSame topicGenomics and Rare DiseasesFrench-language works237,207